Concepedia

Xue Shui

XS

Statistics

Publications

6

Citations

310

H-Index

6

Active since

2009

Affiliations

Dicerna Pharmaceuticals (United States)(Current)

Xue Shui is an author at Dicerna Pharmaceuticals (United States) specializing in medicine, pharmacology, and cancer cell biology.

Top concepts

Publications per year

2009–2022

6

Publications

6

RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade

Shanthi Ganesh, Xue Shui, Kevin P. Craig et al. · Molecular Therapy · 2018 · 120 citations · Full text

, , +18

Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1

Chaitali Dutta, Nicole Avitahl-Curtis, Natalie W. Pursell et al. · Molecular Therapy · 2016 · 82 citations · Full text

Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin

Shanthi Ganesh, Martin L. Koser, Wendy A. Cyr et al. · Molecular Cancer Therapeutics · 2016 · 61 citations · Full text

, , +21

β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models

Shanthi Ganesh, Xue Shui, Kevin P. Craig et al. · Molecular Cancer Therapeutics · 2017 · 21 citations · Full text

Monoamine oxidase A drives neuroendocrine differentiation in prostate cancer

Xue Shui, Xuehua Ren, Rong Xu et al. · Biochemical and Biophysical Research Communications · 2022 · 14 citations

, , +3

1–5 of 6